PulpVAZ ™, a patent-pending, compounded antibiotic (Ciprofloxacin 14%, Metronidazole 43%, Clindamycin 43%) treatment system for dental practitioners to provide a disinfection protocol for the treatment of non-vital pulps. Revascularization is performed on immature permanent teeth that have become necrotic and infected and are immature.

» Learn More

See PulpVaz in Action

PulpVAZ is "Lesion Sterilization and Tissue Repair", non-instrumentation, "in-office", endodontic treatment, which involves...

» Learn More

What is PulpVAZ™?

PulpVAZ employs the use of a patent-pending, 2-part system consisting of a mixture of antibacterial drugs for disinfection of coronal and root canal dentin in order to heal pulpal and periapical lesions.

» Learn More

Indications for PulpVAZ

1. Pulpotomy in primary teeth
2. Root canal disinfection (and filling) in primary teeth
3. Revascularization of immature permanent teeth
4. Intracanal disinfection of mature infected teeth

Click the link below to download the PulpVAZ order form and PulpVAZ mixing instructions.

» How to order



"The triple antibiotic paste has become popular in recent years for a variety of dental indications. PulpVaz is the culmination of many years of development in order to make the acquisition, storage and use of this antibiotic combination efficient and safe for dentists and patients. I feel that PulpVaz is now in a form that is ideal for routine use for many dental applications."

- Dr. Trope

MedCara Pharmaceuticals
126 N Main
Conrad, Iowa 50621
Phone: 515.577.6758 |Email
NuCara Pharmacy
1150 5th Street, Suite 140
Coralville, Iowa 52241
Toll Free Ph: 877.268.2272
Ph: 319.354.6006|Fx: 866.354.6381|Email
MedCara Pharmaceuticals NuCara Pharmaceuticals
© 2020 MedCara Pharmaceuticals. All rights reserved. Sitemap|Feedback
The information contained in this website is provided for educational purposes only and is not intended to replace discussions with your healthcare provider. All decisions regarding a patients' treatment must be made with a healthcare provider. PulpVAZ� and PulpHEALTM are available as a compounded medication exclusively from MedCara Pharmaceuticals and dispensed under an exclusive contract by NuCara Pharmacy. PulpVAZ and PulpHEAL as formulations have not been through FDA testing. PulpVAZ and PulpHEAL have been compounded under prescription from a licensed professional and is dispensed under a specific patient name. MedCara Pharmaceuticals and NuCara Pharmacy does not make any claims, overt or implied, of the safety or effectiveness of the PulpVAZ or PulpHEAL compounds. We refer only to references pertaining to peer reviewed medical publications and/or safety studies endorsed by the FDA. In keeping with FDA regulations, MedCara Pharmaceutical�s intentions are to provide pertinent and informative facts and information that will assist a person in making a well informed and educated decision about his/her medical care.
© 2020 MedCara Pharmaceuticals. All Rights Reserved.